Volume 5, Number 6—December 1999
Toxic Shock Syndrome in the United States: Surveillance Update, 1979–19961
|Characteristic||1979-80 (n = 1,392)||No. (%)a by years 1981-86 (n = 2,835)||1987-96 (n = 1,069)||Total cases (n = 5,296)|
|Female||1,365 (98)||2,594 (92)||958 (90)||4,917 (93)|
|Median age (yrs), (range)||21 (1-70)||22 (1-87)||25 (3d-82)||22 (3d-87)|
|White race||1,067 (77)||2,564 (90)||967 (90)||4,598 (91)|
|Menstrual cases||1,264 (91)||2,021 (71)||636 (59)||3,921 (74)|
|Deaths (Case-fatality ratio [%])||77 (6)||95 (3.5)||36 (3.5)||208 (4)|
aCalculations were done by using as denominator the number of persons for whom the information on the specific characteristic was available.
- U.S. Public Health Services. Addressing emerging infectious disease threats. A prevention strategy for the United States. Atlanta: Centers for Disease Control and Prevention; 1994.
- Todd JK, Kapral FA, Fishaut M, Welch TR. Toxic shock syndrome associated with phage group 1 staphylococci. Lancet. 1978;2:1116–8. DOIPubMedGoogle Scholar
- Centers for Disease Control and Prevention. Toxic-shock syndrome–United States. MMWR Morb Mortal Wkly Rep. 1980;29:229–30.
- Broome CV. Epidemiology of toxic shock syndrome in the United States: Overview. Rev Infect Dis. 1989;2(Suppl 1):S14–21.
- Shands KN, Schmid GP, Dan BB, Blum D, Guidotti RJ, Hargrett NT, Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases. N Engl J Med. 1980;303:1436–42.PubMedGoogle Scholar
- Centers for Disease Control and Prevention. Toxic shock syndrome–United States. MMWR Morb Mortal Wkly Rep. 1980;:2979.
- Centers for Disease Control and Prevention. Follow-up on toxic-shock syndrome. MMWR Morb Mortal Wkly Rep. 1980;29:441–5.
- Reingold AL, Hargrett NT, Shands KN, Dan BB, Schmid GP, Strickland BY, Toxic shock syndrome surveillance in the United States, 1980 to 1981. Ann Intern Med. 1982;96:875–80.PubMedGoogle Scholar
- Gaventa S, Reingold AL, Hightower AW, Broome CV, Schwartz B, Hoppe C, Active surveillance for toxic shock syndrome in the United States. 1986. Rev Infect Dis. 1989;2(Suppl 1):S28–34.
- Davis JP, Chesney PJ, Wand PJ, LaVenture M. Toxic-shock syndrome: epidemiologic features, recurrence, risk factors and prevention. N Engl J Med. 1980;303:1429–35.PubMedGoogle Scholar
- Latham RH, Kehrberg MW, Jacobson JA. Toxic shock syndrome in Utah: a case-control and surveillance study. Ann Intern Med. 1982;96:906–8.PubMedGoogle Scholar
- Schuchat A, Broome CV. Toxic shock syndrome and tampons. Epidemiol Rev. 1991;13:99–112.PubMedGoogle Scholar
- Centers for Disease Control and Prevention. Reduced incidence of menstrual toxic shock syndrome–United States, 1980-1990. MMWR Morb Mortal Wkly Rep. 1990;39:421–4.PubMedGoogle Scholar
- Petitti DB, Reingold AL. Update through 1985 on the incidence of toxic shock syndrome among members of a prepaid health plan. Rev Infect Dis. 1989;11(Suppl 10):S22–7.PubMedGoogle Scholar
- Schlievert PM. Comparison of cotton and cotton/rayon tampons for effect on production of toxic shock syndrome toxin. J Infect Dis. 1995;172:1112–4.PubMedGoogle Scholar
- Simonsen L, Conn LA, Pinner RW, Teutsch S. Trends in infectious disease hospitalizations in the United States, 1980-1994. Arch Intern Med. 1998;158:1923–8. DOIPubMedGoogle Scholar
- Hughes D, Stapleton J. Postoperative toxic shock syndrome. Iowa Med. 1991;81:55–8.PubMedGoogle Scholar
- Lindsay J, Ruzin A, Ross HF, Kurepina N, Novick RP. The gene for toxic shock toxin is carried by a family of mobile pathogenicity islands in Staphylococcus aureus. Mol Microbiol. 1998;29:527–43. DOIPubMedGoogle Scholar
1Presented in part at the European Conference on Toxic Shock Syndrome, Royal Society of Medicine, London, September 1997, and at the International Conference on Emerging Infectious Diseases, Atlanta, March 1998. (Arbuthnott J, Furman B, editors. European conference on toxic shock syndrome, 1997. London [UK]: The Royal Society of Medicine Press Limited; 1998.)